Hillert, Jan
Article History
First Online: 26 February 2020
Competing interests
: J.H. has received honoraria for serving on advisory boards for Biogen, Celgene, Merck KGaA, Novartis, Sandoz and Sanofi Genzyme and speaker’s fees from Biogen, Merck KGaA, Novartis, Sanofi Genzyme and Teva. He has served as principal investigator for projects, or received unrestricted research support from, Biogen, Celgene, Merck KGaA, Novartis, Roche and Sanofi Genzyme. His multiple sclerosis research is funded by the Swedish Research Council and the Swedish Brain foundation.